Convince Your Boss Letter
If you need to seek approval to attend the 7th Annual e-Discovery Pharma, Biotechnology & Medical Devices Summit, please review this document to facilitate the approval process
Ensuring Information Protection in the Electronic Communication Age
In today's age of electronic communication, the ability to properly protect, monitor and disseminate information being transferred becomes more difficult. In this podcast, Joseph Mariano, a Records System Analyst in the Pharmaceutical Industry, discusses new innovative processes and solutions to ensure proper protection and distribution of information.
Protecting the Life Science Industry’s Intellectual Property with the SAFE BioPharma Standard
Protecting intellectual property and timely regulatory filings are crucial to the business practices of life science organizations, so a legally defensible and speedy process is necessary for optimal productivity. In this podcast, Mollie Shields-Uehling, President and CEO, SAFE-BIOPharma Association, discusses the “SAFE BioPharma Standard” that was established to provide the legal, regulatory, technical and risk management framework to allow the biopharmaceutical industry to move toward a fully electronic process.
E-Discovery Technology. Beware of Vapourware!
HB Gordon, eDiscovery Analyst, Legal Affairs, Teva Pharmaceuticals USA, joins Andrea Charles from Pharma IQ, to discuss the current challenges associated with e-discovery in pharma and biotech, approaching cross-broder privacy and data protection issues and the biggest gap today between e-discovery vendor offerings and legal end-user needs.
Case in Point: Causal Elements in the Evolution of eDiscovery
In this exclusive interview featuring Ronald Hedges, former US Magistrate, District of New Jersey, we explore the changing nature of eDiscovery and the contributing case law. We ask Ronald his opinion on the impact of the Duke conference and if he forsee’s any major changes to the federal rules on civil procedure. In an ever evolving legal landscape, we also discuss how social media is affecting the scope of eDiscovery (as seen in the case of McMillen vs Hummingbird Speedway)
What’s Ahead for the Federal Rules and eDiscovery
Former United States Magistrate Judge Ronald Hedges discusses eDiscovery and what lies ahead for federal rules. Hedges spoke at Legal IQ's 2010 eDiscovery for Pharma and Biotech event
Evaluating and Improving Your Litigation Hold Processes
The best way to avoid costly disputes regarding the adequacy of eDiscovery processes and collections is to build a defensible litigation hold business process. Jeffrey Ritter has over 25 years experience in law, technology and academic research, and joins us in this podcast to give some insights on navigating the rules that govern digital information.
Utilizing Generally Accepted Recordkeeping Principles (GARP) to Develop a Good eDiscovery Strategy
ARMA International’s Generally Accepted Recordkeeping Principles (GARP) and its associated Information Governance Maturity Model (Maturity Model) are tools that an organization can use to develop a reasonable, good faith program to properly manage all information, from creation through disposition, thereby reducing costs, stress, disruptions and other issues when responding to a document request. In this interview, Melissa Dederer, CRM, Associate Director of Records Management at Purdue Pharma, offers a deeper understanding of GARP and its associated Maturity Model to help you be better prepared (proactive) rather than running around (reactive) when the request for information is received.
Achieving the Balance Between E-Discovery Mandates and Health Provider-Specific Privacy Obligations
Although many health facilities have invested in high-tech records management systems (EMR/HER), those systems do not encompass the entire information and data environment within a health facility and sensitive information often finds its way into and onto systems outside the reach of EMR/HER systems. This brings with it increased exposures to security breach and liability. In this Q&A interview, Chad P. Brouillard, Esq. Partner, Foster & Eldridge, LLP speaks with Legal IQ about achieving the balance between e-Discovery mandates and health provider-specific privacy obligations.
Walking the Lines of Transparency and Attorney-Client Privilege for Electronically Stored Information
In the highly litigious pharma and biotech industries, outside counsel must ensure that they have conducted adequate due diligence in managing and producing electronic evidence. In this Q&A interview, Sarah Jane Gillet, Partner at Hall Estill, joins Legal IQ to address some issues faced by outside counsel, and offers some insight into preserving client confidences and where the line of transparency lies.
How to Create an eDiscovery Team that Works for your Organization
With budget constraints and reduced internal staffing putting pressure on in-house corporate departments that analyze and make decisions on an ever-increasing pool of potentially discoverable material, creating a solid in-house eDiscovery team is a big challenge. In this interview, H.B. Gordon, eDiscovery Analyst, Legal Affairs, at Teva Pharmaceuticals USA, explains how to leverage your current corporate organization structure to create a solid in-house eDiscovery team.
Interim Report on Preservation and Spoliation
This July 28, 2011 report by the New York State Bar Association’s Special Committee on Discovery and Case Management in Federal Litigation addresses issues relating to the preservation and spoliation of electronically stored information, documents and things, including whether changes in the Federal Rules of Civil Procedure are necessary. It provides an overview of current federal case law concerning when and what information is to be preserved, the scope of the duty to preserve, and the elements of a spoliation claim, as well as standards for preservation and remedies and sanctions for spoliation.
Research Collaboration in the Cloud: How NCI and Research Partners are using Interoperable Identities, Digital Signatures and Cloud Computing to Accelerate Drug Development
Whitepaper by SAFE-BioPharma Association
E-Discovery Defensibility: Views from the Bench
Defensibility is core to a wide range of processes that may ultimately come under judicial scrutiny. In many ways, the search for what is “defensible” is one of the most fundamental risk management tasks that legal practitioners undertake on a daily basis. This Whitepaper by Clearwell explores defensibility in the context of electronic discovery.
Emerging Trends in Electronic Health Record Liability
Given recent governmental incentives for medical practices and institutions to implement electronic health record software, much attention has focused on the efficiencies and technical advances of these new applications. In this article by By Chad P. Brouillard Esq. Foster & Eldridge, LLP, read about the potential for new risks and liabilities this can create for your clients.
Can Social Media Play a Role in E-Discovery?
Due to the important role that such files can play in the dealings of businesses, it is unsurprising that the past few months have thrown up some debate around e-discovery, particularly its relationship with social media. Read More.
Avoiding Costly Mistakes in eDiscovery
Some 44 percent said they expected the challenges surrounding eDiscovery to increase, with 39 per cent predicting they will be dedicating more resources to the task.
Implementing Effective RIM Awareness
Presentation by Joseph M. Mariano, Records System Analyst, Information Governance at Boehringer Ingelheim USA Corp.